2022. Ozempic (Semaglutide) for the treatment of obesity: advantages and disadvantages from an integrative analysis. Research, Society and Development. 11, 11 (Sep. 2022), e587111133963 . DOI:https://doi.org/10.33448/rsd-v11i11.33963.